Thierry Dorval
AstraZeneca R&D
Cambridge, ENG, United Kingdom
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
A seeding-based neuronal model of tau aggregation for use in drug discovery.
Journal: PloS one
Published: October 03, 2022
Development of a chemogenomics library for phenotypic screening.
Journal: Journal of cheminformatics
Published: August 14, 2021
Mathematical modeling of the microtubule detyrosination/tyrosination cycle for cell-based drug screening design.
Journal: PLoS computational biology
Published: July 09, 2021
From high content screening to target deconvolution: New insights for phenotypic approaches
Journal: Medecine sciences : M/S
Published: March 19, 2021
Filling the drug discovery gap: is high-content screening the missing link?
Journal: Current opinion in pharmacology
Published: May 03, 2018
From the Cover: High-Throughput Imaging of Cardiac Microtissues for the Assessment of Cardiac Contraction during Drug Discovery.
Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: January 11, 2017
SLAS Europe High-Content Screening Conference in Dresden: A Glimpse of the Future?
Journal: Journal of biomolecular screening
Published: September 22, 2016
A non-randomized dose-escalation Phase I trial of a protein-based immunotherapeutic for the treatment of breast cancer patients with HER2-overexpressing tumors.
Journal: Breast cancer research and treatment
Published: March 03, 2016
A phase I/II trial of the safety and clinical activity of a HER2-protein based immunotherapeutic for treating women with HER2-positive metastatic breast cancer.
Journal: Breast cancer research and treatment
Published: March 03, 2016
Immunofluorescence microscopy of SNAP23 in human skeletal muscle reveals colocalization with plasma membrane, lipid droplets, and mitochondria.
Journal: Physiological reports
Published: January 07, 2016
Last Updated: 09/26/2026